Status:
RECRUITING
Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk
Lead Sponsor:
University of Chicago
Conditions:
Menopausal
Dementia
Eligibility:
FEMALE
40-58 years
Phase:
NA
Brief Summary
By age 45, women's lifetime risk of dementia is estimated to be 1 in 5. Two-thirds of people currently living with a dementia diagnosis are women, and-women make up the majority of carers for people w...
Eligibility Criteria
Inclusion
- Female sex at birth
- Aged between 40-58 years
- Late perimenopause or early post-menopause
- Elevated dementia risk characterized by first degree relative with diagnosis of Alzheimer's disease or another dementia
Exclusion
- Diagnosis of Mild Cognitive Impairment, Alzheimer's or another dementia
- Diagnosis of other chronic illness or condition that affects cognition (e.g., Axis I psychiatric disorders such as schizophrenia or mood disorders, neurological disorders such as stroke, cancer, traumatic brain injury)
- Inadequate vision or hearing to engage with intervention materials
- Unable or unwilling to provide informed consent
- Iatrogenic menopause (i.e., due to surgery)
Key Trial Info
Start Date :
January 31 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06965686
Start Date
January 31 2025
End Date
December 30 2025
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medicine
Chicago, Illinois, United States, 60637